The serum protein lipopolysaccharide (LPS) (14, 21) . In rabbit macrophages, LBP-LPS complexes were 1,000-fold more active than LPS alone in tumor necrosis factor (TNF) induction (14).
Lipopolysaccharide (LPS) is a major component of the outer envelope of gram-negative bacteria. It is believed to play a major role in the serious clinical consequences of gram-negative bacterial infections, leading to fever, disseminated intravascular coagulation, shock, and possibly death (20) . The immune system of the host, particularly the cells of the monocytic lineage, has been shown to play a pivotal role in the mediation of the biological effects of LPS, namely, the overproduction of cytokines (5, 12, 15) . Since the first description of the presence of LPS-binding protein (LBP) in the serum of rabbits (18) , a model to explain the presentation of LPS to cells of the monocytic lineage has been proposed. LPS first forms a complex with LBP in blood; this complex binds to CD14 on the surface of monocytes, resulting in increased expression of LPS-inducible genes (14, 21) . In rabbit macrophages, LBP-LPS complexes were 1,000-fold more active than LPS alone in tumor necrosis factor (TNF) induction (14) .
LBPs from humans and rabbits have been cloned and sequenced (14) . The high DNA sequence homology in these two species suggests that other species could share a similar mechanism of LBP-mediated recognition of LPS. Mice are often used in experimental models of LPS inoculation or of gram-negative bacterial infections. The purification of mouse LBP and the development of specific anti-LBP reagents would be helpful in determining the role played by LBP in the response to LPS.
We report here on the purification of mouse LBP and on some of the properties of the protein. As MATERIALS AND METHODS Materials. Escherichia coli 0111 LPS, either native or labeled with fluorescein isothiocyanate (FITC-LPS), was purchased from Sigma (St. Louis, Mo.). The following strains of mice were used in this study: OF1, C57BL/6J, CBA/J, DBA/2, and BALB/c (IFFA Credo); and C3H/HeN and C3H/HeJ (Harlan). Serum was collected by bleeding through the retroorbital plexus; the blood was allowed to clot at 37°C for 1 h and at 0°C overnight, centrifuged, and stored frozen. Acute-phase mouse serum (APMS) was collected 8, 16 , and 24 h after induction of an acute-phase response by subcutaneous injection of 0.2 ml of 3% (wt/vol) silver nitrate in water with a protocol similar to that designed for the acute-phase response in rabbits (18) . Polyclonal antiserum to mouse LBP was raised in rabbits by subcutaneous injection of 10 ,ug of purified LBP in complete Freund adjuvant followed by two successive booster injections of LBP in incomplete Freund adjuvant given at 3 and at 6 weeks. Rabbit antibodies were purified by protein A affinity chromatography.
Purification of LBP. APMS was collected from OF1 mice 24 h after subcutaneous injection of silver nitrate. APMS was fractionated with 20 ml of Bio-Rex 70 resin (Bio-Rad Laboratories, Basel, Switzerland) equilibrated with 40 mM NaCl in 50 mM phosphate buffer (pH 7.3) containing 2 mM EDTA (phosphate-EDTA). Then 5 mM EDTA was added to APMS; 300 ml of APMS was run over the column, and the column was washed with phosphate-EDTA until the A280 of the eluate was <0.02 absorbance unit. The flow-through fraction was kept for measuring residual LBP activity. Protein absorbed to the resin (Bio-Rex eluate) was eluted with a linear gradient of 40 to 1 M NaCl in phosphate-EDTA. Pools of fractions to be tested for LBP activity were dialyzed against 50 mM phosphate buffer (pH 7.3 ) and concentrated to a 10-ml volume by using YM10 membranes in an Amicon ultrafiltration cell (Amicon Corp., Danvers, Mass.).
Fractions containing LBP activity were adsorbed on a Mono-Q column (Pharmacia, Uppsala, Sweden) equilibrated in 50 mM phosphate buffer (pH 8.2). The material was eluted by high-pressure liquid chromatography (chromatograph from Beckman Instruments, Berkeley, Calif.). After injection of the sample, proteins were eluted with the following concentrations of saline in phosphate buffer: no saline for the first 20 fractions (1 ml each), 150 mM saline for fractions 20 to 60, 300 mM saline for fractions 60 to 85, and then a linear gradient up to 1 M saline. Fractions containing LBP activity were pooled, dialyzed against phosphate buffer (pH 7.3), and concentrated to a final volume of 1 ml. Methods for sequencing. Samples were reduced with 2-mercaptoethanol and then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 6% acrylamide gels (10) . After electrophoresis, gels were stained with Coomassie blue, and parallel gels were transferred to nitrocellulose sheets. The blotted proteins were reversibly stained with 0.5% Ponceau S (Serva, Heidelberg, Germany) in 1% acetic acid. The strip containing the antigen (LBP) was cut apart. This material was sequenced by automated Edman degradation with an Applied Biosystems 470 A Protein Sequenator attached to a 120 A PTH analyzer in the presence of Polybrene. Concentration of purified LBP was estimated by absorbance measurement (1 A280 unit was normalized to 1 mg/ml). The reactivity of immune rabbit immunoglobulin G (IgG) fractions for purified mouse LBP was investigated by Western immunoblotting (19) .
Test for LBP activity. Heparinized blood samples obtained from normal donors were used to prepare peripheral blood mononuclear cells (PBMC) by centrifuging blood over Ficoll-Hypaque (Pharmacia, Uppsala, Sweden). PBMC (106) were incubated at 37°C with 1 ,ug of FITC-LPS in 1 ml (final volume) of RPMI medium enriched with the various fractions to be tested for LBP activity or with 1% albumin as a control. After 1 h of incubation, the cells were washed twice with cold phosphate-buffered saline and analyzed with a FACScan flow cytometer (Becton Dickinson). The fluorescence signal was recorded on a logarithmic scale expressed in fluorescence units (FU), and the data were analyzed with the Consort-30 software and a lysis program package from Becton Dickinson. To restrict the analysis of monocytes, side-scatter parameters were used to apply computerized gating (16) . In all these experiments, the signal shown by lymphocytes was not significant compared with that shown by monocytes. For CD14 blockade, monocytes were pretreated for 10 min with a CD14-specific monoclonal antibody, MY4 (Coulter Immunology, Luton, England) (7), used at 10 ,ug/ ml. TNF release of human monocytes. PBMC (0.5 x 106) were suspended in 250 ,ul of RPMI medium supplemented with 10% serum or with purified LBP in each well of 96-well flat bottom microtiter plates (Becton Dickinson). The cells were stimulated with nonfluoresceinated 0111 LPS at the indicated concentrations. Supernatants were collected for TNF measurements after 4 h of culture at 37°C. At that time, the release of TNF was optimal. Under the conditions used in this study, TNF release by peripheral blood lymphocytes present in the PBMC fraction was negligible (8) . TNF was measured with WEHI-clone 13 cells as described previously (1, 4) .
RESULTS
Screening of LBP activity. We LPS on human monocytes (9) . Fluorescence-activated cell sorter (FACS) analysis was used to measure the binding of FITC-LPS to human monocytes; the presence of rabbit LBP resulted in increased binding relative to that in controls without LBP. Similar results were observed with rabbit serum or with purified rabbit LBP. The increased binding in serum was suppressed by immunodepletion of LBP. The binding was also suppressed by CD14 blockade of monocytes, confirming previous observations that the binding of LPS-LBP complexes was restricted to the CD14 of monocytes (21) .
In the present experiments, we used human monocytes, because there is no available blocking antibody to CD14 of mouse monocytes. Similar findings were observed when mouse serum was used instead of rabbit serum (Fig. 1) (Fig. 3) , no residual LBP activity was found in nonadsorbed proteins (Fig. 3a) . LBP activity was found in the whole Bio-Rex eluate after concentration (Fig. 3b) .
LBP was purified further on a Mono-Q column by highpressure liquid chromatography. Figure 2b shows the absorbance profile of the Bio-Rex eluate passed over the column after elution with increasing concentrations of NaCl. Among the various collected fractions, only fractions eluted with <150 mM (Fig. 2b, fraction c) contained LBP activity as measured by FACS analysis (Fig. 3c) . All other tested fractions (Fig. 2b, fractions d , e, f, g, and h) had no LBP activity.
The LBP-containing fractions were pooled, concentrated, and dialyzed against phosphate buffer (pH 7.3). An SDS-PAGE gel of fractions from different steps of the purification of mouse LBP is shown in Fig. 4 Amino acid sequence data. The NH2 sequence TNPGLV TRIT was obtained from purified mouse LBP (Table 1) . The 10-amino-acid sequence was used to search for homologous sequences in the GenBank and EMBL data bases. This procedure resulted in matches only to human and rabbit LBPs and to human and bovine bacterial permeabilityincreasing proteins, which are structurally related to LBP (14) .
Responses of mouse LBP to temperature and pH changes. (Fig.  5a ). When APMS was incubated with FITC-LPS in the presence of immune rabbit IgG, the fluorescence decreased to 3 FU (Fig. Sb) , which was the level of binding to control complexes did not prevent the complex from binding to CD14.
Presence of LBP in normal mouse serum and APMS. LBP has been described as an acute-phase reactant in rabbits (18), but it can also be detected in normal rabbit serum (9) . We estimated the levels of mouse LBP in normal mouse sera and APMS by diluting sera from 10% to 0.01% and by measuring FITC-LPS binding on monocytes.
In all strains of mice tested, the addition of normal serum down to 0.1% still promoted a positive fluorescence signal over that in control monocytes incubated in 1% albumin. Below 0.01%, mouse serum from all strains of mice tested behaved like the 1% albumin control (data not shown).
The kinetics of the acute-phase response in mice was measured. APMS was collected in all strains 8, 16 , and 24 h after injection of silver nitrate. Very similar levels of LBP activity were found from 8 to 24 h (only data from 24 h are shown). LBP activity increased in APMS relative to that measured in normal sera ( Table 2 ). The LPS binding measured in 1% APMS was quite similar to that of 10% normal serum, except for C3H/HeJ mice. In that strain, a high LBP activity was already observed in 10% normal serum and did not increase significantly after induction of the acute phase. However, this activity in normal serum dropped when serum was diluted to 1%, suggesting that the affinity of LBP in C3H/HeJ mice might differ from that in other mouse strains. Similar results were observed in a second experiment with another batch of C3H/HeJ mice.
LBP-mediated release of TNF by human monocytes. LBPmediated binding has been shown to strikingly increase TNF secretion by human monocytes in both human serum and rabbit serum (14, 21) . We thus investigated the ability of mouse serum and purified mouse LBP to increase TNF release by human monocytes. PBMC were stimulated with 0.1 to 100 ng of 0111 LPS per ml, and supernatants were assayed for TNF activity with WEHI clone 13 cells (Table  3) . When incubation of PBMC was done in RPMI without serum, at least 10 to 100 ng of LPS per ml was necessary to trigger TNF release in three separate experiments. When PBMC were incubated in 10% human serum or 10% APMS, stimuli in the range of 0.1 to 1 ng/ml (depending on the donor) were sufficient for triggering PBMC; i.e., the sensitivity of PBMC to LPS increased at least 100-fold. Cells incubated in serum released larger amounts of TNF than did cells incubated in medium alone. Purified LBP in the absence of LPS was not active in inducing TNF but was able to substitute for total serum in increasing the sensitivity of monocytes to LPS. In all incubation media, pretreatment of monocytes with anti-CD14 monoclonal antibody MY4 suppressed TNF release at LPS concentrations of 10 to 100 ng/ml.
DISCUSSION
The complex effects of LPS in mammals include activation of the immune system, which results in an overproduction of cytokines such as TNF and interleukin-1. The initial events that control the activation of monocytes are of special interest. Recent studies have assigned an important role to serum (3) , and more specifically to LBP (9, 14, 21) , in mediating presentation of LPS to monocytes. Complexes of LPS and LBP are recognized by cell surface CD14. This report provides further evidence supporting this model, showing that mice share with humans and rabbits a similar mechanism of recognition of LPS.
Originally, rabbit LBP was purified in acute-phase rabbit serum and detected by centrifugation in a CsCl density gradient (18) . We were successful in purifying mouse LBP by detecting LBP with a different detection system, i.e., FACS analysis of the binding to monocytes of complexes of LBP and fluorescent LPS. Anti-LBP antibodies suppressed the serum-mediated binding of LPS in acute-phase serum. A similar suppression was found with CD14 blockade of human monocytes. These experiments strongly argue for the formation of an LPS-LBP complex in mouse serum, which is presented to CD14 of human monocytes, in parallel with the mechanism described previously for rabbit and human LBPs (14, 21) . On mouse macrophages, an LBP-mediated activa- By analogy with human monocytes, binding of LPS-LBP complexes to CD14 on mouse macrophages is likely, but we cannot demonstrate this because we lack blocking anti-CD14 reagents for mouse macrophages. The ability of mouse LBP to increase the sensitivity of human monocytes to minute concentrations of LPS was comparable to the activity of human or rabbit LBP (14, 21) . LBP was found to be a major mouse serum protein that increases LPS binding to monocytes. LBP was present in sufficient amounts in normal mouse serum to signal the presence of LPS to monocytes, since increased LPS binding was detected in normal sera diluted down to 0.1%. An acute-phase response further induced LBP synthesis in mice, as previously described for rabbits (18) . Precise measurements of LBP levels in mouse serum will need appropriate quantification with immunoassays and anti-LBP reagents. Our binding experiments suggest a 10-fold increase of LBP after an acute-phase response. All strains of mice, except C3H/HeJ mice, shared this mechanism. Surprisingly, the LBP activity was elevated in 10% normal serum from C3H/HeJ mice but dropped sharply when the serum was diluted to 1%. This could suggest a difference in the amount of LBP and in its affinity for LPS or CD14 in C3H/HeJ mice. These findings are worthy of further investigation, because C3H/HeJ mice are highly resistant to LPS (13) .
The isolation and characterization of mouse LBP have shown that the NH2-terminal sequences in the whole family of LBP, including LBP and bacterial permeability-increasing proteins, are very similar (6, 11, 14, 17) . The high degree of sequence homology of LBPs among various animal species could explain the finding that fetal calf, human, and rabbit LBPs present LPS to human monocytes in similar ways (9, 14, 21) . LBPs from all these species promote the binding of LPS to human CD14 and trigger TNF production by monocytes. Similar conclusions also apply to mouse LBP, as shown in the present study, again suggesting a highly conserved manner of signaling the presence of minute amounts of LPS to immune cells in normal and acute-phase sera (9) .
The further development of monoclonal antibodies to mouse LBP and to mouse CD14 will, it is hoped clarify the role played in vivo by LBP in response to LPS, challenge.
